These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23361094)

  • 1. Effects of methylnaltrexone on guinea pig gastrointestinal motility.
    Anselmi L; Huynh J; Vegezzi G; Sternini C
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Apr; 386(4):279-86. PubMed ID: 23361094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone.
    Beattie DT; Cheruvu M; Mai N; O'Keefe M; Johnson-Rabidoux S; Peterson C; Kaufman E; Vickery R
    Naunyn Schmiedebergs Arch Pharmacol; 2007 May; 375(3):205-20. PubMed ID: 17340127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of the opioid antagonist N-methylnaltrexone and evaluation of its effects on gastrointestinal tract function in horses treated or not treated with morphine.
    Boscan P; Van Hoogmoed LM; Pypendop BH; Farver TB; Snyder JR
    Am J Vet Res; 2006 Jun; 67(6):998-1004. PubMed ID: 16740093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the potential role of methylnaltrexone in opioid bowel dysfunction.
    Foss JF
    Am J Surg; 2001 Nov; 182(5A Suppl):19S-26S. PubMed ID: 11755893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of methylnaltrexone on morphine-induced inhibition of contraction in isolated guinea-pig ileum and human intestine.
    Yuan CS; Foss JF; Moss J
    Eur J Pharmacol; 1995 Mar; 276(1-2):107-11. PubMed ID: 7781680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health.
    Wong BS; Rao AS; Camilleri M; Manabe N; McKinzie S; Busciglio I; Burton DD; Ryks M; Zinsmeister AR
    Aliment Pharmacol Ther; 2010 Oct; 32(7):884-93. PubMed ID: 20839388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of methylnaltrexone and naloxone on esophageal motor function in man.
    Scarpellini E; Pauwels A; Vos R; Rommel N; Tack J
    Neurogastroenterol Motil; 2017 Mar; 29(3):. PubMed ID: 28110513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orally administered opioid antagonists reverse both mu and kappa opioid agonist delay of gastrointestinal transit in the guinea pig.
    Culpepper-Morgan JA; Holt PR; LaRoche D; Kreek MJ
    Life Sci; 1995; 56(14):1187-92. PubMed ID: 7475895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-release but not immediate-release and subcutaneous methylnaltrexone antagonizes the loperamide-induced delay of whole-gut transit time in healthy subjects.
    Kolbow J; Modess C; Wegner D; Oswald S; Maritz MA; Rey H; Weitschies W; Siegmund W
    J Clin Pharmacol; 2016 Feb; 56(2):239-45. PubMed ID: 26313157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of the mu-opioid receptor in gastrointestinal pathophysiology: therapeutic opportunities for antagonism at this receptor.
    DeHaven-Hudkins DL; DeHaven RN; Little PJ; Techner LM
    Pharmacol Ther; 2008 Jan; 117(1):162-87. PubMed ID: 18022696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of peripheral opioid receptors by methylnaltrexone does not prevent morphine tolerance in rats.
    Blomqvist KJ; Dudek KA; Viisanen H; Mätlik K; Ahlström FHG; Laitila J; Kalso EA; Rauhala PV; Lilius TO
    J Neurosci Res; 2022 Jan; 100(1):329-338. PubMed ID: 32459013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylnaltrexone crosses the blood-brain barrier and attenuates centrally-mediated behavioral effects of morphine and oxycodone in mice.
    Walentiny DM; Komla E; Moisa LT; Mustafa MA; Poklis JL; Akbarali HI; Beardsley PM
    Neuropharmacology; 2021 Mar; 185():108437. PubMed ID: 33316279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation.
    Singleton PA; Moreno-Vinasco L; Sammani S; Wanderling SL; Moss J; Garcia JG
    Am J Respir Cell Mol Biol; 2007 Aug; 37(2):222-31. PubMed ID: 17395891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of methylnaltrexone on morphine-induced cough suppression in guinea pigs.
    Foss JF; Orelind E; Goldberg LI
    Life Sci; 1996; 59(15):PL235-8. PubMed ID: 8845013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of gastrointestinal function by MuDelta, a mixed µ opioid receptor agonist/ µ opioid receptor antagonist.
    Wade PR; Palmer JM; McKenney S; Kenigs V; Chevalier K; Moore BA; Mabus JR; Saunders PR; Wallace NH; Schneider CR; Kimball ES; Breslin HJ; He W; Hornby PJ
    Br J Pharmacol; 2012 Nov; 167(5):1111-25. PubMed ID: 22671931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation.
    Singleton PA; Lingen MW; Fekete MJ; Garcia JG; Moss J
    Microvasc Res; 2006; 72(1-2):3-11. PubMed ID: 16820176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
    Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
    Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu-opioid receptor.
    Gorur A; Patiño M; Shi T; Corrales G; Takahashi H; Rangel R; Gleber-Netto FO; Pickering C; Myers JN; Cata JP
    J Cell Physiol; 2021 Nov; 236(11):7698-7710. PubMed ID: 34038587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of the effect of the opioid antagonist N-methylnaltrexone on motility of the equine jejunum and pelvic flexure.
    van Hoogmoed LM; Boscan PL
    Equine Vet J; 2005 Jul; 37(4):325-8. PubMed ID: 16028621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of methylnaltrexone, a peripheral opioid receptor antagonist, and its role in opioid-induced constipation.
    Shaiova L; Rim F; Friedman D; Jahdi M
    Palliat Support Care; 2007 Jun; 5(2):161-6. PubMed ID: 17578067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.